Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 673

1.

Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.

Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S.

J Infect. 2006 Dec;53(6):357-63. Epub 2006 Feb 17.

PMID:
16487593
2.

Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis.

Tansuphasawadikul S, Saito W, Kim J, Phonrat B, Dhitavat J, Chamnachanan S, Pitisuttithum P.

Southeast Asian J Trop Med Public Health. 2007 Nov;38(6):1053-60.

PMID:
18613546
3.

Characteristics of HIV-infected tuberculosis patients in Thailand.

Mankatittham W, Likanonsakul S, Thawornwan U, Kongsanan P, Kittikraisak W, Burapat C, Akksilp S, Sattayawuthipong W, Srinak C, Nateniyom S, Tasaneeyapan T, Varma JK.

Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):93-103.

PMID:
19323040
4.

Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis.

Michailidis C, Pozniak AL, Mandalia S, Basnayake S, Nelson MR, Gazzard BG.

Antivir Ther. 2005;10(3):417-22.

PMID:
15918332
5.

Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.

Hung CC, Chen MY, Hsiao CF, Hsieh SM, Sheng WH, Chang SC.

AIDS. 2003 Dec 5;17(18):2615-22.

PMID:
14685055
6.

HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.

Kingkaew N, Sangtong B, Amnuaiphon W, Jongpaibulpatana J, Mankatittham W, Akksilp S, Sirinak C, Nateniyom S, Burapat C, Kittikraisak W, Monkongdee P, Varma JK.

Int J Infect Dis. 2009 Nov;13(6):722-9. doi: 10.1016/j.ijid.2008.11.013. Epub 2009 Feb 4.

7.

Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.

Conesa-Botella A, Loembé MM, Manabe YC, Worodria W, Mazakpwe D, Luzinda K, Mayanja-Kizza H, Miri M, Mbabazi O, Koole O, Kestens L, Colebunders R; TB IRIS Group.

J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):463-8. doi: 10.1097/QAI.0b013e31823801de.

PMID:
21963941
8.

Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy.

Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):42-6.

PMID:
16885778
9.

Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.

Moore D, Liechty C, Ekwaru P, Were W, Mwima G, Solberg P, Rutherford G, Mermin J.

AIDS. 2007 Mar 30;21(6):713-9.

PMID:
17413692
10.

Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand.

Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Vibhagool A.

J Infect. 2006 Mar;52(3):188-94. Epub 2005 Jun 29.

PMID:
15992932
11.

Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?

Breen RA, Smith CJ, Cropley I, Johnson MA, Lipman MC.

AIDS. 2005 Jul 22;19(11):1201-6.

PMID:
15990574
12.

Treatment outcomes of patients co-infected with tuberculosis and HIV at Chiang Mai University Hospital, Thailand.

Limmahakhun S, Chaiwarith R, Nuntachit N, Sirisanthana T, Supparatpinyo K.

Int J STD AIDS. 2012 Jun;23(6):414-8. doi: 10.1258/ijsa.2012.011291.

PMID:
22807535
13.

Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.

Worodria W, Menten J, Massinga-Loembe M, Mazakpwe D, Bagenda D, Koole O, Mayanja-Kizza H, Kestens L, Mugerwa R, Reiss P, Colebunders R; TB-IRIS Study Group.

Antivir Ther. 2012;17(5):841-8. doi: 10.3851/IMP2108. Epub 2012 Apr 27.

PMID:
22543224
14.

Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.

Sungkanuparph S, Eampokalap B, Chottanapund S, Bed ST, Manosuthi W.

J Med Assoc Thai. 2007 May;90(5):884-8.

PMID:
17596041
15.

Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy.

Elliott JH, Vohith K, Saramony S, Savuth C, Dara C, Sarim C, Huffam S, Oelrichs R, Sophea P, Saphonn V, Kaldor J, Cooper DA, Chhi Vun M, French MA.

J Infect Dis. 2009 Dec 1;200(11):1736-45. doi: 10.1086/644784.

PMID:
19874177
16.

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL.

AIDS. 2002 Jan 4;16(1):75-83.

PMID:
11741165
17.

Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand.

Sirinak C, Kittikraisak W, Pinjeesekikul D, Charusuntonsri P, Luanloed P, Srisuwanvilai LO, Nateniyom S, Akksilp S, Likanonsakul S, Sattayawuthipong W, Burapat C, Varma JK.

BMC Public Health. 2008 Jul 18;8:245. doi: 10.1186/1471-2458-8-245.

19.

Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis.

Burman W, Weis S, Vernon A, Khan A, Benator D, Jones B, Silva C, King B, LaHart C, Mangura B, Weiner M, El-Sadr W.

Int J Tuberc Lung Dis. 2007 Dec;11(12):1282-9.

PMID:
18229435
20.

Outcomes of antituberculosis treatments at 18 months follow-up in TB-HIV co-infected patients on ART: a retrospective review of 166 cases.

Chunpongthong P, Ko ZZ, Yeekian C, Luvira V, Pitisuttithum P.

J Med Assoc Thai. 2011 Jun;94(6):664-70.

PMID:
21696073

Supplemental Content

Support Center